Nucs AI Overview
- Year Founded
-
2024
- Status
-
Private
- Employees
-
15
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$3.5M
- Investors
-
1
Nucs AI General Information
Description
Developer of an artificial intelligence-driven platform designed to assist healthcare professionals in the clinical management of prostate cancer. The company's platform provides tools for comprehensive tumour analysis and personalised treatment predictions, enabling clinicians to make evidence-based decisions for personalised cancer care and avoid ineffective treatments.
Contact Information
Website
www.nucs.aiCorporate Office
- 368 9th Avenue
- New York, NY 10001
- United States
Corporate Office
- 368 9th Avenue
- New York, NY 10001
- United States
Nucs AI Timeline
Nucs AI Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Seed Round | 16-Sep-2024 | $3.5M | Completed | Generating Revenue | ||
| 1. Seed Round | 01-Mar-2024 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Nucs AI Patents
Nucs AI Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260187545-A1 | Systems and methods for coordinating execution of an ensemble of machine learning models | Pending | 02-Aug-2024 | ||
| WO-2026030680-A1 | Systems and methods for coordinating execution of an ensemble of machine learning models | Pending | 02-Aug-2024 | ||
| EP-4789146-A1 | A process for automatic generation of structured medical report for cancer imaging | Pending | 05-Oct-2023 | ||
| WO-2025074147-A1 | A process for automatic generation of structured medical report for cancer imaging | Inactive | 05-Oct-2023 | ||
| US-20260237479-A1 | Systems and methods for generating electronic medical reports using positron emission tomography or single-photon emission computed tomography with computed tomography images | Pending | 05-Oct-2023 | G16H15/00 |
Nucs AI Signals
Nucs AI Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| AuroraAxis Capital | Venture Capital | Minority |
Nucs AI FAQs
-
When was Nucs AI founded?
Nucs AI was founded in 2024.
-
Where is Nucs AI headquartered?
Nucs AI is headquartered in New York, NY.
-
What is the size of Nucs AI?
Nucs AI has 15 total employees.
-
What industry is Nucs AI in?
Nucs AI’s primary industry is Other Healthcare Technology Systems.
-
Is Nucs AI a private or public company?
Nucs AI is a Private company.
-
What is Nucs AI’s current revenue?
The current revenue for Nucs AI is .
-
How much funding has Nucs AI raised over time?
Nucs AI has raised $3.5M.
-
Who are Nucs AI’s investors?
AuroraAxis Capital has invested in Nucs AI.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process